Generic Name:

Ferric Carboxymaltose 1000mg

Storage Condition:

Store below 30°C

Packing:

1 Vial

Mfg / Mkd By:

Lupin Ltd

Doses:


Therapeutic Use:

Anemia

Description:

Introduction :

Dolphin Pharmaceuticals is a leading largest Ferric Carboxymaltose supplier from India, based in Surat, Gujarat, specializing in the supply of high-quality specialty medicines. We serve pharmacy, distributors, hospitals, and healthcare organizations worldwide with quality-assured Ferric Carboxymaltose.

Ferric Carboxymaltose is primarily used for the treatment of Anemia, under the supervision of qualified healthcare professionals. Dolphin Pharmaceuticals is providing medicines, competitive pricing, complete support, and global healthcare requirements.

Ferinject 50 mg/mL Solution for Injection

Ferinject (Ferric Carboxymaltose) 50 mg/mL Solution for Injection is an iron replacement medicine marketed by Lupin Ltd. in India. Its composition is ferric carboxymaltose equivalent to 50 mg of elemental iron per mL. It belongs to the parenteral iron preparations (antianemic agents) drug class and is used to treat iron deficiency anemia when oral iron supplements are ineffective, cannot be tolerated, or rapid iron replacement is required. It helps replenish the body's iron stores and supports hemoglobin and red blood cell production, improving oxygen transport throughout the body. Ferric Carboxymaltose is administered intravenously by a qualified healthcare professional under medical supervision.

Product Introduction

Ferinject 50 mg/mL Solution for Injection is an iron replacement medicine used to treat iron deficiency anemia and iron deficiency associated with certain medical conditions, including chronic kidney disease. It contains ferric carboxymaltose, which helps replenish the body's iron stores and supports the production of healthy red blood cells.

Iron is essential for producing hemoglobin, the protein in red blood cells responsible for carrying oxygen throughout the body. Restoring iron levels can help improve symptoms such as fatigue, weakness, and reduced energy caused by iron deficiency.

Ferric Carboxymaltose is administered intravenously by a qualified healthcare professional through an injection or infusion. The dosage and frequency depend on the patient's iron requirements, body weight, and medical condition. Patients are monitored during and after administration for possible adverse reactions.

Common side effects may include nausea, headache, dizziness, flushing, skin rash, injection-site reactions, and decreased phosphate levels in the blood. Patients should inform their healthcare professional about any existing medical conditions, allergies, or medicines they are taking before treatment. Ferric Carboxymaltose should be used only under appropriate medical supervision.

Uses of Ferric Carboxymaltose Solution for Injection

o Treatment of iron deficiency anemia.

o Treatment of iron deficiency in patients with chronic kidney disease, when clinically indicated.

Benefits of Ferric Carboxymaltose Solution for Injection

Ferric Carboxymaltose helps replenish depleted iron stores, supporting the production of hemoglobin and red blood cells. By improving iron availability, it can help restore the body's oxygen-carrying capacity and relieve symptoms associated with iron deficiency, including tiredness, weakness, and reduced physical stamina.

Its intravenous administration allows iron to be delivered directly into the bloodstream, making it a treatment option for patients who require intravenous iron or cannot adequately benefit from oral iron preparations.

Side Effects of Ferric Carboxymaltose Solution for Injection

Possible side effects include:

o Nausea and vomiting

o Headache and dizziness

o Flushing or a sensation of warmth

o Skin rash

o Pain, swelling, or redness at the injection site

o Decreased phosphate levels in the blood

o Changes in blood pressure

Most side effects are manageable, but patients should inform their healthcare professional if symptoms persist or become troublesome. Serious allergic reactions can occur, so monitoring during and after administration is important.

How Ferric Carboxymaltose Solution for Injection Works

Ferinject contains ferric carboxymaltose, an iron-containing compound that supplies iron for the body's normal physiological processes. The supplied iron is utilized to replenish iron stores and support hemoglobin synthesis and red blood cell production. This helps improve iron deficiency and supports the delivery of oxygen to tissues throughout the body.

Precautions and Warnings

Ferric Carboxymaltose should be used only when iron deficiency has been confirmed and treatment is considered appropriate. Patients should inform their healthcare professional if they have liver disorders, asthma, allergies, inflammatory conditions, or other relevant medical conditions.

Use during pregnancy or breastfeeding should be discussed with a healthcare professional. Blood tests may be required before and after treatment to assess iron levels, hemoglobin, and other relevant parameters. Phosphate monitoring may also be appropriate in patients at risk of low phosphate levels or those receiving repeated treatment.



Our Other Products

View All
Kabidarba (Darbepoetin alfa)

Kabidarba (Darbepoetin alfa) 40 mcg

Generic Name: Darbepoetin alfa 40 mcg

Injection
Packaging:0.40 ml Pre-Filled Syringe
Mfg / Mfd By:Fresenius Kabi Oncology Ltd
Storage Condition:2°C TO 8°C Temperature
Therapeutic Use:
Treat anemia associated with chronic kidney disease and, in selected patients, anemia caused by chemotherapy.
Trombopag (Eltrombopag Olamine)

Trombopag (Eltrombopag Olamine) 50 mg

Generic Name: Eltrombopag Olamine

Tablet
Packaging:4 x 7 Tablet
Mfg / Mfd By:Natco Pharma Ltd
Storage Condition:Store below 30°C
Therapeutic Use:
Aplastic Anaemia, Thrombocytopenia
Cresp (Darbepoetin alfa)

Cresp (Darbepoetin alfa) 40 mcg

Generic Name: Darbepoetin alfa 40mcg

Injection
Packaging:40 mcg / 0.4 ml
Mfg / Mfd By:Dr. Reddy’s Laboratories Ltd
Storage Condition:Store in a refrigerator (2° - 8°C). Do not freeze.
Therapeutic Use:
Treat anemia associated with chronic kidney disease and, in selected patient anemia caused by chemotherapy.